


Healthcare News Roundup: FDA
HSMN NewsFeed - 8 Feb 2022
atHeart Medical Receives FDA Approval for the Second Phase of the ASCENT ASD U.S. IDE Trial
atHeart Medical Receives FDA Approval for the Second Phase of the ASCENT ASD U.S. IDE Trial
HSMN NewsFeed - 7 Feb 2022
US FDA "Study May Proceed" Letter for Clarity's Cu-64 SAR-bisPSMA Trial in Prostate Cancer
US FDA "Study May Proceed" Letter for Clarity's Cu-64 SAR-bisPSMA Trial in Prostate Cancer
HSMN NewsFeed - 7 Feb 2022
Check-Cap Announces FDA Approval of Amended IDE Application for Pivotal Study of C-Scan
Check-Cap Announces FDA Approval of Amended IDE Application for Pivotal Study of C-Scan
HSMN NewsFeed - 28 Jan 2022
FDA Accepts Label Update for Plasma IQ(TM), the First FDA-Cleared Handheld Plasma Energy Device
FDA Accepts Label Update for Plasma IQ(TM), the First FDA-Cleared Handheld Plasma Energy Device
HSMN NewsFeed - 18 Jan 2022
Endomina(R) System, a New Suturing Tool for Use by Gastroenterologists Receives FDA Clearance
Endomina(R) System, a New Suturing Tool for Use by Gastroenterologists Receives FDA Clearance
HSMN NewsFeed - 3 Jan 2022
Zynex Submits FDA Application for its Next Generation Fluid and Blood Volume Monitor
Zynex Submits FDA Application for its Next Generation Fluid and Blood Volume Monitor
HSMN NewsFeed - 27 Dec 2021
Nobel Biocare Receives FDA 510(k) Clearance for the Nobel Biocare N1(TM) Implant System
Nobel Biocare Receives FDA 510(k) Clearance for the Nobel Biocare N1(TM) Implant System
